Mark Jacobson

Chief Operating Officer at AXSOME THERAPEUTICS, INC.

Net worth: - $ as of 2024-04-29

40 year

Health Technology

Consumer Services

Mark Jacobson active positions

Companies	Position	Start	End
AXSOME THERAPEUTICS, INC.	Chief Operating Officer	2014-03-31	-
	Investor Relations Contact	2014-03-31	-
	Corporate Secretary	2015-09-30	-

Companies	Position	Start	End
STEMLINE THERAPEUTICS, INC.	Corporate Officer/Principal	2009-06-30	2014-02-28

Iowa State University	Undergraduate Degree
The Trustees of Columbia University in The City of New York	Graduate Degree

International

United States

Operational

Corporate Officer/Principal	1
Undergraduate Degree	1
Graduate Degree	1

Sectoral

Health Technology	3
Consumer Services	3

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
AXSOME THERAPEUTICS, INC.	Health Technology

Private companies	1
Stemline Therapeutics, Inc. Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignancies. The SL-801, is a novel oral small molecule reversible inhibitor of XPO1, that has demonstrated in vivo and in vitro preclinical activity in solid and hematologic malignancies. The SL-701, is an immunotherapy designed to activate the immune system to attack tumors. The company was founded by Ivan Bergstein on August 8, 2003 and is headquartered in New York, NY.	Health Technology

Private companies

Health Technology